BMC » Cancer Nanotechnology
40 FOLLOWERS
Cancer Nanotechnology aims to provide a forum so that the most promising emerging themes should be pre-eminent in the minds of researchers working in one-or, indeed, both-of the disciplines of cancer research or nanotechnology.
BMC » Cancer Nanotechnology
1w ago
Nanocarrier delivery of small interfering RNAs (siRNAs) to silence cancer-associated genes is a promising method for cancer treatment. Here, we explored the role and mechanisms of PLAG NPs-delivered si-Notch1 ..read more
BMC » Cancer Nanotechnology
3w ago
Colorectal cancer (CRC) ranks as the third most common cancer globally and the second leading cause of cancer-related mortality. Traditional chemotherapy, while effective, often results in significant side eff ..read more
BMC » Cancer Nanotechnology
1M ago
The addition of the cyclin dependent kinase inhibitor (CDKi) dinaciclib to Poly-(ADP-ribose) polymerase inhibitor (PARPi) therapy is a strategy to overcome resistance to PARPi in tumors that exhibit homologous ..read more
BMC » Cancer Nanotechnology
1M ago
The delivery of therapeutic nucleic acids, such as small interfering RNA (siRNA) and antisense oligonucleotides (ASO) into cells, is widely used in gene therapy. Gold nanoparticles (AuNPs) have proved to be ef ..read more
BMC » Cancer Nanotechnology
1M ago
There is a continuous growth of interest in the development of nano-drug delivery systems that could combine therapy and diagnosis of cancer ..read more
BMC » Cancer Nanotechnology
1M ago
It is crucial to enhance new compounds for the treatment of most malignancies, and graphene oxide/silver nanocomposite (GO/Ag NC) has been paying attention to biomedical applications such as malignancies. In t ..read more
BMC » Cancer Nanotechnology
2M ago
Colorectal cancer (CRC) is a type of cancer that affects the colon or rectum and occurs in individuals over the age of 50, although it can affect people of all ages. Quercetin is a flavonoid, which is a type o ..read more
BMC » Cancer Nanotechnology
2M ago
Hepatocellular carcinoma (HCC) is a common malignant tumor with high mortality and recurrence rate. The efficacy of the first-line drug sorafenib is impeded by drug resistance, which is closely related to acti ..read more
BMC » Cancer Nanotechnology
2M ago
The medical field is faced with the difficult task of developing a new approach to curing cancer, which is prevalent in organs such as the breast and ovaries and has a high mortality rate. Since chemotherapy i ..read more
BMC » Cancer Nanotechnology
2M ago
Nowadays, silver nanoparticles (AgNPs) have attracted the attention of many researchers due to their special physical, chemical, and biological properties. There is strong evidence that biogenic AgNPs can act ..read more